Literature DB >> 1447745

Cardiotonic agents. Synthesis and cardiovascular properties of novel 2-arylbenzimidazoles and azabenzimidazoles.

T Güngör1, A Fouquet, J M Teulon, D Provost, M Cazes, A Cloarec.   

Abstract

Novel 2-arylbenzimidazoles and azabenzimidazoles were synthesized, and their inotropic action was evaluated. Changes in left ventricular pressure, dP/dt max, were measured as an index of cardiac contractility. The structural features that impart optimal inotropic activity are presented. The most potent compounds were evaluated orally in conscious dogs with implanted Konigsberg pressure transducers. To investigate the mechanism of action, the most potent compounds were tested for their calcium-sensitizing properties and their potential for the inhibition of phosphodiesterase. Two compounds, 1 and 41, showed interesting in vitro and oral activity without side effects. They have a more potent calcium-sensitizing effect than MCI-154 and are under further investigation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1447745     DOI: 10.1021/jm00101a024

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Synthesis and biological evaluation of analogues of AKT (protein kinase B) inhibitor-IV.

Authors:  Qi Sun; Runzhi Wu; Sutang Cai; Yuan Lin; Llewlyn Sellers; Kaori Sakamoto; Biao He; Blake R Peterson
Journal:  J Med Chem       Date:  2011-02-14       Impact factor: 7.446

2.  Iron oxide encapsulated by copper-apatite: an efficient magnetic nanocatalyst for N-arylation of imidazole with boronic acid.

Authors:  Othmane Amadine; Younes Essamlali; Abdallah Amedlous; Mohamed Zahouily
Journal:  RSC Adv       Date:  2019-11-11       Impact factor: 4.036

3.  An Efficient Greener Approach for N-Acylation of Amines in Water Using Benzotriazole Chemistry.

Authors:  Tarek S Ibrahim; Israa A Seliem; Siva S Panda; Amany M M Al-Mahmoudy; Zakaria K M Abdel-Samii; Nabil A Alhakamy; Hani Z Asfour; Mohamed Elagawany
Journal:  Molecules       Date:  2020-05-28       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.